25 November 2020
Independent biomedical research and treatment centre for life-threatening diseases City of Hope initiated a Phase I clinical trial of its investigational SARS-CoV-2 vaccine among healthy participants between the ages of 18 and 55 years with no prior SARS-CoV-2 infection.
Go deeper with GlobalData
Allero Therapeutics and Abbreos have announced a collaboration to clinically test the latter’s novel OroMucosal ImmunoGlobulin (OMIG) that addresses medical conditions associated with lethal amounts of pro-inflammatory cytokines and chemokines. The first focus of the initiative is to treat patients who are likely to suffer from Covid-19-associated acute respiratory distress syndrome (ARDS), and if not treated, require intensive care and ventilation.
Eli Lilly has signed a $32.5m agreement with Canada to supply 26,000 doses of its antibody drug bamlanivimab to treat Covid-19 patients. The treatment was developed by Canadian biotech company AbCellera and is expected to be supplied to Canada between December and February.
A European Union (EU) official confirmed that the European Commission has signed a vaccine supply deal with Moderna. Moderna’s mRNA-1273 vaccine candidate met its primary efficacy endpoint in a Phase III COVE study with 94.5% efficacy.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
